KOPIN; Alan S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for KOPIN; Alan S..The latest application filed is for "methods and systems for designing and/or characterizing soluble lipidated ligand agents".

Company Profile

4.6.19

KOPIN; Alan S. - Wellesley MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Systems For Designing And/or Characterizing Soluble Lipidated Ligand Agents App 20220135633 - COHEN; Charles ; et al.	2022-05-05
Compounds And Methods For Treating Inflammation App 20220054581 - COHEN; Charles ; et al.	2022-02-24
Methods and systems for designing and/or characterizing soluble lipidated ligand agents Grant 11,254,720 - Cohen , et al. February 22, 2	2022-02-22
Methods of lowering blink reflex for the treatment of dry eye disease Grant 11,197,906 - Cohen , et al. December 14, 2	2021-12-14
Compounds And Methods For The Treatment Of Autism Spectrum Disorder And Other Neurological Or Psychiatric Disorders App 20210236438 - Draper; Isabelle ; et al.	2021-08-05
Targeted Treatment Of Autism Spectrum Disorder And Other Neurological Or Psychiatric Disorders App 20210228531 - Draper; Isabelle ; et al.	2021-07-29
Compounds And Methods For Treating Pain App 20210101934 - KOPIN; Alan S. ; et al.	2021-04-08
Compounds and methods for treating pain Grant 10,899,796 - Kopin , et al. January 26, 2	2021-01-26
Methods and Systems for Designing and/or Characterizing Soluble Lipidated Ligand Agents App 20190135882 - Cohen; Charles ; et al.	2019-05-09
Methods and systems for designing and/or characterizing soluble lipidated ligand agents Grant 10,233,219 - Cohen , et al.	2019-03-19
Compounds And Methods For Treating Inflammation App 20190022168 - Cohen; Charles ; et al.	2019-01-24
Compounds And Methods For Treating Pain App 20180319842 - Kopin; Alan S. ; et al.	2018-11-08
Compounds and methods for the treatment of muscular disease, and related screening methods Grant 9,662,314 - Draper , et al. May 30, 2	2017-05-30
Methods And Systems For Designing And/or Characterizing Soluble Lipidated Ligand Agents App 20160052982 - Cohen; Charles ; et al.	2016-02-25
Compositions and Methods for the Treatment of Muscular Disease, and Related Screening Methods App 20140243378 - Draper; Isabelle ; et al.	2014-08-28
Methods of altering absorption of hydrophobic compounds App 20060177438 - Kopin; Alan S. ; et al.	2006-08-10
Mutation induced optimization of receptor signal to noise ratio App 20040214992 - Kopin, Alan S. ; et al.	2004-10-28
Rapid methods for assessing therapeutic activity using animals expressing constitutively active G protein coupled receptors App 20040049800 - Kopin, Alan S. ; et al.	2004-03-11
Assay for and uses of peptide hormone receptor agonists App 20030191114 - Kopin, Alan S. ; et al.	2003-10-09
Assay for non-peptide agonists to peptide hormone receptors App 20030180798 - Kopin, Alan S. ; et al.	2003-09-25
Dose response-based methods for identifying receptors having alterations in signaling App 20030148390 - Kopin, Alan S. ; et al.	2003-08-07
Dose response-based methods for identifying receptors having alterations in signaling App 20030087313 - Kopin, Alan S. ; et al.	2003-05-08
Constitutively active, hypersensitive, and nonfunctional recepors as novel therapeutic agents App 20020147170 - Kopin, Alan S. ; et al.	2002-10-10
Assays for identifying receptors having alterations in signaling App 20020127539 - Kopin, Alan S. ; et al.	2002-09-12
Assay for non-peptide agonists to peptide hormone receptors Grant 5,750,353 - Kopin , et al. May 12, 1	1998-05-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.